Foghorn Therapeutics Inc (FHTX)

SG&A Expense Growth

-2.85%

Fiscal year · Period ending:

FHTX logo

FHTX SG&A Expense Growth

Latest reported-2.85%
FHTX FY SG&A Growth (YoY) (0.00% → -2.85%)
High-resolution chart · PNG

FHTX sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Foghorn Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
-2.8527%
-12.3965%
5.2851%
41.5087%
93.2065%
128.1599%
2.1766%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.